In the last decade, independent groups have reported an overexpression of the glycoprotein Cluster Differentiation 90 (CD90) in several cancers, including melanoma, pancreatic adenocarcinoma (PDA), hepatocellular carcinoma (HCC), and ovarian cancer [9,10,11,12]. Here, THY1 is linked to hepatocellular carcinoma.